title: Chondroitin sulfate proteoglycan expression and binding of Plasmodium falciparum-infected erythrocytes in the human placenta during pregnancy.
abstract: A characteristic feature of malaria during pregnancy is the sequestration of Plasmodium falciparum-infected red blood cells (IRBCs) in the intervillous spaces of the placenta. We have recently shown that unusually low-sulfated chondroitin sulfate proteoglycans (CSPGs) present in the intervillous spaces mediate the adherence of IRBCs in the placenta. In areas of endemicity, the prevalence of P. falciparum infection in pregnant women peaks during weeks 13 to 20 and then gradually declines, implying that the placental CSPGs are available for IRBC adhesion early during the pregnancy. However, there is no information on the expression and composition of CSPGs during pregnancy. In this study, the expression pattern of CSPGs during the course of pregnancy was investigated. The CSPGs were purified from placentas of various gestational ages, characterized, and tested for the ability to bind IRBCs. The data demonstrate that the CSPGs are present in the intervillous spaces throughout the second and third trimesters. The levels of CSPGs expressed per unit tissue weight were similar in placentas of various gestational ages. However, the structures of the intervillous-space CSPGs changed considerably during the course of pregnancy. In particular, the molecular weight was decreased, with an accompanying gradual increase in the CSPG size polydispersity, from 16 weeks until 38 weeks. The sulfate content was increased considerably after 24 weeks. Despite these structural changes, the CSPGs of placentas of various gestational ages efficiently supported the binding of IRBCs. These results demonstrate that CSPGs can mediate the sequestration of IRBCs in the intervillous spaces of the placenta during the entire second and third trimesters and possibly during the later part of the first trimester as well.
authors.affiliation: Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, D.C. 20007, USA.
authors.forename: Sean T
authors.initials: ST
authors.lastname: Agbor-Enoh
authors.forename: Rajeshwara N
authors.initials: RN
authors.lastname: Achur
authors.forename: Manojkumar
authors.initials: M
authors.lastname: Valiyaveettil
authors.forename: Rose
authors.initials: R
authors.lastname: Leke
authors.forename: Diane W
authors.initials: DW
authors.lastname: Taylor
authors.forename: D Channe
authors.initials: DC
authors.lastname: Gowda
mesh_terms: D000818:Animals; D002448:Cell Adhesion; D011508:Chondroitin Sulfate Proteoglycans / Q000378:metabolism*; D004912:Erythrocytes / Q000378:metabolism* / Q000469:parasitology*; D005260:Female; D005865:Gestational Age; D006801:Humans; D016778:Malaria, Falciparum / Q000469:parasitology*; D010920:Placenta / Q000469:parasitology*; D010963:Plasmodium falciparum / Q000502:physiology*; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000469:parasitology*
chemical_list: D011508:Chondroitin Sulfate Proteoglycans